Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

The 2022 Tandem Meetings | Reducing the toxicity of conditioning in HSC gene therapy

Luigi Naldini • 7 Apr 2022
The 2022 Tandem Meetings
General

Luigi Naldini, MD, PhD, San Raffaele Telethon Institute for Gene Therapy, Milano, Italy, talks on the toxicity associated with chemotherapy or radiotherapy-based conditioning prior to hematopoietic stem cell (HSC) gene therapy in hematological diseases. Prof. Naldini underlines the importance of exploring strategies to reduce the short-term and long-term toxicity of these regimens, as well as to assess milder conditioning strategies. This interview took place at the Transplantation & Cellular Therapy (TCT) Meetings of ASTCT™ and CIBMTR® 2022 in Salt Lake City, Utah.

More from Luigi Naldini

0:57
Advances in tools for genetic engineering of HSCs
Luigi Naldini • 7 Apr 2022
1:32
Lentiviral vectors for HSC gene therapy
Luigi Naldini • 7 Apr 2022

Related Videos

2:30
The impact of conflict on access to cancer therapies
Richard Sullivan • 29 Apr 2024
3:11
Exercise as an underutilized tool in cancer care
Rebecca Robinson • 23 Apr 2024
2:15
Cardiac biomarkers for immune checkpoint inhibitor-related myocarditis in cancer patients
Arjun Ghosh • 25 Apr 2024
1:09
Rethinking healthcare to improve affordability, sustainability, and patient outcomes
Richard Sullivan • 29 Apr 2024
The content of VJHemOnc is intended for healthcare professionals